Security key
14888U101
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 82,218,793
- Share change
- -6,142,688
- Total reported value
- $1,104,943,728
- Put/Call ratio
- 31%
- Price per share
- $13.44
- Number of holders
- 243
- Value change
- -$95,298,712
- Number of buys
- 117
- Number of sells
- 125
Report period
Q2 2023
Institutions
243
Top holders
10
CPRX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
CATALYST PHARMACEUTICALS, INC. SEC filings
CATALYST PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14888U101
Recent filing periods:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
12%
|
15,360,310
|
$254,673,945 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
8.4%
|
10,355,099
|
$171,687,541 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
6.1%
|
7,542,718
|
$125,058,264 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
6,926,446
|
$114,840,474 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
2,374,508
|
$39,369,035 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,854,222
|
$30,743,012 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.3%
|
1,577,692
|
$26,158,133 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,428,313
|
$23,681,430 | — | 31 Mar 2023 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
1.2%
|
1,423,584
|
$23,603,023 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,392,655
|
$23,090,221 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,355,095
|
$22,467,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.99%
|
1,219,175
|
$20,213,921 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.99%
|
1,218,994
|
$20,210,921 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.96%
|
1,184,425
|
$19,637,767 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.96%
|
1,179,422
|
$19,554,817 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
1,136,737
|
$18,847,099 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.92%
|
1,134,848
|
$18,815,780 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.88%
|
1,090,100
|
$18,074,000 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.84%
|
1,029,679
|
$17,073,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.8%
|
985,880
|
$16,345,891 | — | 31 Mar 2023 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.78%
|
957,800
|
$15,880,000 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.76%
|
934,738
|
$15,497,956 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.66%
|
818,998
|
$13,578,987 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.66%
|
812,206
|
$13,466,375 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.61%
|
751,353
|
$12,457,000 | — | 31 Mar 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.6%
|
744,609
|
$12,345,618 | — | 31 Mar 2023 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.5%
|
615,968
|
$10,212,749 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.5%
|
613,499
|
$10,171,813 | — | 31 Mar 2023 | |
| JW Asset Management, LLC |
13F
|
Company |
0.46%
|
563,392
|
$9,341,039 | — | 31 Mar 2023 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.42%
|
513,734
|
$8,517,710 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
502,928
|
$8,338,546 | — | 31 Mar 2023 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.39%
|
478,305
|
$7,930,297 | — | 31 Mar 2023 | |
| Artemis Investment Management LLP |
13F
|
Company |
0.38%
|
468,932
|
$7,757,120 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.38%
|
464,667
|
$7,704,179 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
455,239
|
$7,547,862 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.35%
|
432,304
|
$7,167,600 | — | 31 Mar 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.35%
|
430,767
|
$7,142,116 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.35%
|
429,613
|
$7,122,984 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.35%
|
429,303
|
$7,117,844 | — | 31 Mar 2023 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.33%
|
409,080
|
$6,782,546 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.31%
|
387,670
|
$6,427,569 | — | 31 Mar 2023 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.3%
|
370,057
|
$6,135,546 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.29%
|
362,517
|
$6,010,529 | — | 31 Mar 2023 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.27%
|
335,900
|
$5,569,222 | — | 31 Mar 2023 | |
| Quantedge Capital Pte Ltd |
13F
|
Company |
0.26%
|
324,700
|
$5,383,526 | — | 31 Mar 2023 | |
| Advisors Asset Management, Inc. |
13F
|
Company |
0.26%
|
318,748
|
$5,284,842 | — | 31 Mar 2023 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.25%
|
311,750
|
$5,168,815 | — | 31 Mar 2023 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.25%
|
304,191
|
$5,043,487 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.23%
|
288,949
|
$4,790,774 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.23%
|
280,781
|
$4,655,000 | — | 31 Mar 2023 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2023
As of 30 Jun 2023,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
243 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,218,793 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, GOLDMAN SACHS GROUP INC, and Invesco Ltd..
This page lists
243
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
256
Q2 2023 holders
243
Holder diff
-13
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.